Column Capital Advisors, LLC Novavax Inc Transaction History

Column Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$6.67 - $9.52 $667 - $952	-100 Reduced 99.01%	1 $0
Q1 2023 May 09, 2023	BUY	$5.76 - $12.48 $178 - $386	31 Added 44.29%	101 $0
Q4 2022 Feb 06, 2023	BUY	$8.86 - $25.04 $8 - $25	1 Added 1.45%	70 $0
Q2 2022 Aug 04, 2022	BUY	$36.28 - $75.29 $2,503 - $5,195	69 New	69 $4,000
Q2 2020 Aug 12, 2020	SELL	$13.86 - $83.61 $14,137 - $85,282	-1,020 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $3,763 - $5,324	1,020 New	1,020 $4,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.